Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.

Weier K, Naegelin Y, Amann M, Magon S, Mueller-Lenke N, Radue EW, Kappos L, Stippich C, Gass A, Sprenger T.

Eur J Neurol. 2013 Mar;20(3):578-83. doi: 10.1111/ene.12052. Epub 2012 Dec 17.

PMID:
23252517
2.

Non-communicating syringomyelia: a feature of spinal cord involvement in multiple sclerosis.

Weier K, Naegelin Y, Thoeni A, Hirsch JG, Kappos L, Steinbrich W, Radue EW, Gass A.

Brain. 2008 Jul;131(Pt 7):1776-82. doi: 10.1093/brain/awn068. Epub 2008 May 31.

PMID:
18515871
3.

Multiple sclerosis and non-communicating syringomyelia: a casual association or linked diseases?

Solaro C, Uccelli A, Gentile R, Lentino C, Mancardi GL, Primavera A.

Acta Neurol Scand. 1999 Oct;100(4):270-3.

PMID:
10510689
4.

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.

Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):407-14. Epub 2007 Jun 5.

PMID:
17550987
5.

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.

Brain. 2007 Aug;130(Pt 8):2211-9. Epub 2007 May 29.

PMID:
17535835
6.

[Multiple sclerosis with syringomyelia--case report].

Deguchi K, Takeuchi H, Yamada A, Katanaka J, Tsukaguchi M, Sasaki I, Nishioka M.

No To Shinkei. 1994 Jan;46(1):65-9. Review. Japanese.

PMID:
8136203
7.

Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.

Lukas C, Knol DL, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Weier K, Radue EW, Gass A, Kappos L, Naegelin Y, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):410-8. doi: 10.1136/jnnp-2014-308021. Epub 2014 Jun 27.

PMID:
24973341
8.

Noncommunicating syringomyelia in multiple sclerosis: detection by magnetic resonance imaging.

Ransohoff RM, Whitman GJ, Weinstein MA.

Neurology. 1990 Apr;40(4):718-21.

PMID:
2320254
10.

Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.

Rovaris M, Agosta F, Sormani MP, Inglese M, Martinelli V, Comi G, Filippi M.

Brain. 2003 Oct;126(Pt 10):2323-32. Epub 2003 Aug 22.

PMID:
12937086
11.

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta.

Paolillo A, Pozzilli C, Giugni E, Tomassini V, Gasperini C, Fiorelli M, Mainero C, Horsfield M, Galgani S, Bastianello S, Buttinelli C.

Eur J Neurol. 2002 Nov;9(6):645-55.

PMID:
12453081
12.

Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis.

Liptak Z, Berger AM, Sampat MP, Charil A, Felsovalyi O, Healy BC, Hildenbrand P, Khoury SJ, Weiner HL, Bakshi R, Guttmann CR.

AJNR Am J Neuroradiol. 2008 Sep;29(8):1465-70. doi: 10.3174/ajnr.A1162. Epub 2008 Jun 12.

13.

Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy.

Taylor I, Butzkueven H, Litewka L, MacGregor LR, Szoeke C, Cook M, Mitchell P, Kilpatrick TJ, Tubridy N.

J Clin Neurosci. 2004 Feb;11(2):153-8.

PMID:
14732374
14.

Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.

Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1109-15. doi: 10.1136/jnnp-2013-306906. Epub 2014 Feb 19.

PMID:
24554101
15.

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, König F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Brück W.

Brain. 2008 Jul;131(Pt 7):1759-75. doi: 10.1093/brain/awn098. Epub 2008 Jun 5.

16.

Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.

Minneboo A, Jasperse B, Barkhof F, Uitdehaag BM, Knol DL, de Groot V, Polman CH, Castelijns JA.

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):917-23. Epub 2007 Dec 12.

PMID:
18077480
17.

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.

Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F.

Brain. 1998 Apr;121 ( Pt 4):687-97.

PMID:
9577394
18.

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.

Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.

Mult Scler. 2009 Feb;15(2):204-11. doi: 10.1177/1352458508098270. Epub 2008 Nov 5.

PMID:
18987104
19.

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.

Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G.

Neurology. 2004 Oct 26;63(8):1439-45.

PMID:
15505162
20.

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G; Italian Devic's Study Group (IDESG).

J Neurol. 2004 Jan;251(1):47-52.

PMID:
14999489

Supplemental Content

Support Center